AI assistant
Sending…
ULTRALIFE CORP — Director's Dealing 2019
Jan 2, 2019
34105_dirs_2019-01-02_46a21a42-ab04-4280-90e1-299f74074468.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2018-12-28
Reporting Person: FAIN PHILIP A (CFO and Treasurer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-12-28 | Common Stock; $.10 par value | M | 6823 | $3.9797 | Acquired | 92229 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-12-28 | Stock Options | $3.9797 | M | 20000 | Acquired | 2019-01-03 | Common Stock (20000) | Direct |
Footnotes
F1: Represents shares of common stock acquired by the Reporting Person upon exercise of options for 20,000 shares of common stock of the Company, net of 13,177 shares of common stock, retained by the Company at a price determined pursuant to the terms of the Company's 2004 Long Term Incentive Plan, in payment of the exercise price for the options and the Reporting Person's individual minimum statutory withholding tax obligation.
F2: Represents exercise of options for 20,000 shares of common stock of the Company.
More from ULTRALIFE CORP
Proxy Solicitation & Information Statement
2026
Jun 2
Proxy Solicitation & Information Statement
2026
Jun 2
Regulatory Filings
2026
Jun 1
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 29
Annual Report
2026
Mar 23
Major Shareholding Notification
2026
Mar 17
Regulatory Filings
2026
Mar 16
Regulatory Filings
2026
Mar 10